These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20056544)

  • 1. The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: the melanocortin agonist paradigm.
    Ovadia O; Linde Y; Haskell-Luevano C; Dirain ML; Sheynis T; Jelinek R; Gilon C; Hoffman A
    Bioorg Med Chem; 2010 Jan; 18(2):580-9. PubMed ID: 20056544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability.
    Hess S; Ovadia O; Shalev DE; Senderovich H; Qadri B; Yehezkel T; Salitra Y; Sheynis T; Jelinek R; Gilon C; Hoffman A
    J Med Chem; 2007 Nov; 50(24):6201-11. PubMed ID: 17983214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity.
    Hess S; Linde Y; Ovadia O; Safrai E; Shalev DE; Swed A; Halbfinger E; Lapidot T; Winkler I; Gabinet Y; Faier A; Yarden D; Xiang Z; Portillo FP; Haskell-Luevano C; Gilon C; Hoffman A
    J Med Chem; 2008 Feb; 51(4):1026-34. PubMed ID: 18220330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
    Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
    Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive Membrane Permeability in Cyclic Peptomer Scaffolds Is Robust to Extensive Variation in Side Chain Functionality and Backbone Geometry.
    Furukawa A; Townsend CE; Schwochert J; Pye CR; Bednarek MA; Lokey RS
    J Med Chem; 2016 Oct; 59(20):9503-9512. PubMed ID: 27690434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A predictive pharmacophore model of human melanocortin-4 receptor as derived from the solution structures of cyclic peptides.
    Sun H; Greeley DN; Chu XJ; Cheung A; Danho W; Swistok J; Wang Y; Zhao C; Chen L; Fry DC
    Bioorg Med Chem; 2004 May; 12(10):2671-7. PubMed ID: 15110848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
    Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
    J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of cyclic peptidosulfonamides as scaffolds for MC4 pharmacophoric groups.
    Wels B; Kruijtzer JA; Garner KM; Adan RA; Liskamp RM
    Bioorg Med Chem Lett; 2005 Jan; 15(2):287-90. PubMed ID: 15603941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
    Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
    J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a novel potent cyclic peptide MC4-ligand by ring-closing metathesis.
    Wels B; Kruijtzer JA; Garner K; Nijenhuis WA; Gispen WH; Adan RA; Liskamp RM
    Bioorg Med Chem; 2005 Jul; 13(13):4221-7. PubMed ID: 15876540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides.
    Ovadia O; Greenberg S; Chatterjee J; Laufer B; Opperer F; Kessler H; Gilon C; Hoffman A
    Mol Pharm; 2011 Apr; 8(2):479-87. PubMed ID: 21375270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides.
    Linde Y; Ovadia O; Safrai E; Xiang Z; Portillo FP; Shalev DE; Haskell-Luevano C; Hoffman A; Gilon C
    Biopolymers; 2008; 90(5):671-82. PubMed ID: 18655141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
    Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
    J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of cyclic peptides with agonist activity at melanocortin receptor-4.
    Odagami T; Tsuda Y; Kogami Y; Kouji H; Okada Y
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3723-6. PubMed ID: 16678415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms.
    Xiang Z; Pogozheva ID; Sorenson NB; Wilczynski AM; Holder JR; Litherland SA; Millard WJ; Mosberg HI; Haskell-Luevano C
    Biochemistry; 2007 Jul; 46(28):8273-87. PubMed ID: 17590021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.